SCHEMBL4486403

SCHEMBL4486403

COC(=O)c1cc2ccccc2n1C

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.67
MCL1 Q07820 1/20 0.67
KDM4E B2RXH2 2/20 0.57
MTNR1A P48039 1/20 0.57
MTNR1B P49286 1/20 0.57
SLC9A1 P19634 1/20 0.56
MAPT P10636 2/20 0.55
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
UTS2R Q9UKP6 1/20 0.49
PHGDH O43175 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29834903 1.00 L3MBTL1 (0.67) L3MBTL1MCL1KDM4EMTNR1AMTNR1B
SCHEMBL28868200 0.85 MCL1 (0.65) L3MBTL1MCL1SLC9A1MAPTKMT2A
SCHEMBL6186271 0.83 MCL1 (0.63) L3MBTL1MCL1MTNR1AMTNR1BSLC9A1
SCHEMBL7884242 0.83 DAO (0.64) L3MBTL1MCL1KDM4EMTNR1AMTNR1B
SCHEMBL4740170 0.83 MTNR1A (0.53) L3MBTL1MCL1KDM4EMTNR1AMTNR1B
SCHEMBL1092502 0.82 KDM4E (0.62) MCL1KDM4ESLC9A1MAPTKMT2A
SCHEMBL17995256 0.82 MCL1 (0.61) L3MBTL1MCL1SLC9A1MAPTKMT2A
SCHEMBL16599480 0.82 MCL1 (0.76) MCL1SLC9A1MAPTKMT2AMEN1
SCHEMBL519307 0.81 MTNR1A (0.52) L3MBTL1MCL1KDM4EMTNR1AMTNR1B
SCHEMBL7873282 0.81 MTNR1A (0.56) L3MBTL1MCL1KDM4EMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114671795-A Indole compound, preparation method and application thereof in aldehyde ketone detection 中国环境科学研究院 2022-06-28 CN claimed
CN-119431394-A Pyridazinone derivatives and medical application thereof 杭州百新生物医药科技有限公司 2025-02-14 CN disclosed
EP-4276534-A1 MASK BLANK, RESIST PATTERN FORMING PROCESS AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION Shin-Etsu Chemical Co., Ltd. (JP) 2023-11-15 EP disclosed
EP-4276533-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2023-11-15 EP disclosed
US-11760773-B2 Small molecule drug conjugates of gemcitabine monophosphate MAVERIX ONCOLOGY, INC. (US) 2023-09-19 US disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed
CN-111205309-B Indole macrocyclic derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-04-07 CN disclosed
CN-112204036-B Macrocyclic fused pyrazoles as MCL-1 inhibitors 苏州亚盛药业有限公司 2022-12-27 CN disclosed
CN-115052880-A Macrocyclic compounds 芝诺管理公司 2022-09-13 CN disclosed
CN-114671795-B Indole compound, preparation method and application thereof in aldehyde ketone detection 中国环境科学研究院 2022-08-19 CN disclosed
US-4836846-A PRE/POST EMERGENCE; WEEDS, GRASSES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-06-06 US disclosed
CN-1003712-B Process for preparing 6- (1-acyl-1-hydroxymethyl or acetoxymethyl) penicillanic acid derivatives 美国辉瑞有限公司 1989-03-29 CN disclosed
US-4764610-A Herbicidal indole sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-08-16 US disclosed
US-4762921-A 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives PFIZER INC. (US) 1988-08-09 US disclosed
US-4675186-A 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives PFIZER INC. (US) 1987-06-23 US disclosed
EP-0201221-A1 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives PFIZER INC. (US) 1986-11-12 EP disclosed
EP-0070698-B1 HERBICIDAL INDOLE SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-11-13 EP disclosed
EP-0070698-A1 Herbicidal indole sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-01-26 EP disclosed
US-RE29834-E PREPARED FROM 4-SULFONYL-1,8-NAPHTHOLACTAMS BAYER AKTIENGESELLSCHAFT (DE) 1978-11-14 US disclosed
US-3959310-A BENZINDOLE BAYER AKTIENGESELLSCHAFT (DT) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760773-B2 Small molecule drug conjugates of gemcitabine monophosphate ZYX, SLC7A5, GMPS L3MBTL1 35/4885MCL1 626/4885KDM4E 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.